Nature Reviews Cardiology
Papers 3559
1 page of 356 pages (3,559 results)
A new study shows that clonal haematopoiesis of indeterminate potential (CHIP)-driver mutations in DNMT3A or TET2 are associated with increased medium-term mortality in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation.
In patients with acute heart failure, treatment with serelaxin, a recombinant form of human relaxin 2, did not reduce the incidence of cardiovascular death or worsening heart failure.
#1Liesl Zühlke (UCT: University of Cape Town)H-Index: 26
#2Karen Sliwa (UCT: University of Cape Town)H-Index: 64
Last.Ntobeko A.B. Ntusi (UCT: University of Cape Town)H-Index: 12
view all 12 authors...
Africa is witnessing an epidemic of cardiovascular disease (CVD), with staggering morbidity and mortality. The spectrum of CVD includes hypertension, rheumatic heart disease, cardiomyopathy, atherosclerotic disease, congenital heart disease and tuberculous pericarditis. Opportunities exist to alter the trajectory of CVD epidemiology but require committed policy makers, functional health systems and an engaged citizenry.
In the PolyIran study, a fixed-dose polypill strategy was more effective than non-pharmacological interventions in reducing the risk of cardiovascular events.
Genotype-guided selection of oral P2Y12 inhibitor therapy (clopidogrel versus prasugrel or ticagrelor) can reduce the incidence of bleeding in patients who have undergone primary percutaneous coronary intervention.
#1Carlo Patrono (CUA: The Catholic University of America)H-Index: 81
#2Colin Baigent (Clinical Trial Service Unit)H-Index: 66
The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the primary prevention of cardiovascular disease. Three trials of low-dose aspirin versus placebo in three populations at increased risk of myocardial infarction or ischaemic stroke in the absence of establ...
3 CitationsSource
Lifelong genetic exposure to lower levels of both LDL cholesterol and systolic blood pressure is associated with an independent, additive and dose-dependent decrease in the risk of major coronary events.
In patients with STEMI and multivessel coronary artery disease, a strategy of revascularizing both the culprit lesion and any angiographically significant nonculprit lesions achieves better outcomes than a strategy of revascularizing only the culprit lesion.
A novel, community-based model of care led by non-physician health workers significantly reduced blood pressure levels and risk of cardiovascular disease.
Top fields of study
Heart failure
Diabetes mellitus